| Primary |
| Hiv Infection |
46.1% |
| Hepatitis B |
17.1% |
| Product Used For Unknown Indication |
14.0% |
| Amyotrophic Lateral Sclerosis |
2.6% |
| Antiviral Prophylaxis |
2.6% |
| Hepatic Cirrhosis |
2.6% |
| Upper Respiratory Tract Infection |
2.6% |
| Acquired Immunodeficiency Syndrome |
1.3% |
| Cd4 Lymphocytes Decreased |
1.3% |
| Contraception |
1.3% |
| Hypertension |
1.3% |
| Encephalitis |
0.9% |
| Intentional Self-injury |
0.9% |
| Lung Neoplasm Malignant |
0.9% |
| Oral Contraception |
0.9% |
| Pain |
0.9% |
| Psychiatric Symptom |
0.9% |
| Type 2 Diabetes Mellitus |
0.9% |
| Epilepsy |
0.4% |
| Hepatitis C |
0.4% |
|
| Drug Resistance |
8.5% |
| Fanconi Syndrome |
8.5% |
| Blood Pressure Increased |
6.4% |
| Foetal Exposure During Pregnancy |
6.4% |
| Osteomalacia |
6.4% |
| Acute Hepatic Failure |
4.3% |
| Alanine Aminotransferase Increased |
4.3% |
| Anaemia |
4.3% |
| Blood Creatinine Increased |
4.3% |
| Cleft Lip |
4.3% |
| Diabetic Ketoacidosis |
4.3% |
| Hepatitis |
4.3% |
| Maternal Exposure During Pregnancy |
4.3% |
| Multiple Fractures |
4.3% |
| Nausea |
4.3% |
| Renal Failure |
4.3% |
| Renal Impairment |
4.3% |
| Splenomegaly |
4.3% |
| Stillbirth |
4.3% |
| Vomiting |
4.3% |
|
| Secondary |
| Hiv Infection |
42.3% |
| Drug Exposure During Pregnancy |
11.1% |
| Infection |
9.9% |
| Antiretroviral Therapy |
6.8% |
| Maternal Exposure During Pregnancy |
5.5% |
| Prophylaxis Against Hiv Infection |
3.7% |
| Tuberculosis |
3.7% |
| Hepatic Cirrhosis |
2.5% |
| Product Used For Unknown Indication |
2.5% |
| Acquired Immunodeficiency Syndrome |
2.1% |
| Prophylaxis |
2.1% |
| Hepatitis B |
1.6% |
| Amyotrophic Lateral Sclerosis |
1.2% |
| Drug Use For Unknown Indication |
1.2% |
| Hypertension |
1.0% |
| Otitis Externa |
0.8% |
| Psychiatric Symptom |
0.8% |
| Anaemia |
0.4% |
| Gastritis Prophylaxis |
0.4% |
| Hyperlipidaemia |
0.4% |
|
| Drug Exposure During Pregnancy |
12.0% |
| Renal Failure Chronic |
12.0% |
| Maternal Exposure During Pregnancy |
10.0% |
| Anaemia |
8.0% |
| Immune Reconstitution Syndrome |
6.0% |
| Neutropenia |
6.0% |
| Weight Decreased |
6.0% |
| Blood Creatinine Increased |
4.0% |
| Developmental Delay |
4.0% |
| Hydrocele |
4.0% |
| Lung Neoplasm Malignant |
4.0% |
| Pneumonia |
4.0% |
| Thrombocytopenia |
4.0% |
| Ventricular Septal Defect |
4.0% |
| Adrenal Insufficiency |
2.0% |
| Anal Cancer |
2.0% |
| Aspartate Aminotransferase Increased |
2.0% |
| Asthenia |
2.0% |
| Bradycardia |
2.0% |
| Cerebral Atrophy |
2.0% |
|
| Concomitant |
| Hiv Infection |
39.9% |
| Product Used For Unknown Indication |
10.0% |
| Antiretroviral Therapy |
9.5% |
| Prophylaxis |
6.4% |
| Malaria Prophylaxis |
6.2% |
| Vitamin Supplementation |
3.8% |
| Diffuse Large B-cell Lymphoma Stage Iv |
2.6% |
| Antifungal Prophylaxis |
2.3% |
| B-cell Lymphoma |
2.3% |
| Decreased Appetite |
2.0% |
| Mineral Supplementation |
1.9% |
| Prophylaxis Of Nausea And Vomiting |
1.7% |
| Uterine Contractions Abnormal |
1.6% |
| Drug Use For Unknown Indication |
1.5% |
| Pneumocystis Jiroveci Pneumonia |
1.5% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.5% |
| Lymphoma |
1.4% |
| Gastric Ulcer |
1.3% |
| Hepatic Neoplasm Malignant |
1.3% |
| Hepatitis B |
1.3% |
|
| Neutropenia |
30.3% |
| Vomiting |
7.9% |
| Death |
5.6% |
| Pyrexia |
5.6% |
| Fanconi Syndrome |
4.5% |
| Thrombocytopenia |
4.5% |
| White Blood Cell Count Decreased |
4.5% |
| Blood Bilirubin Unconjugated Increased |
3.4% |
| Cellulitis |
3.4% |
| Cushing's Syndrome |
3.4% |
| Hepatitis D |
3.4% |
| Joint Lock |
3.4% |
| Myocardial Infarction |
3.4% |
| Plasmablastic Lymphoma |
3.4% |
| Aids Encephalopathy |
2.2% |
| Alpha 1 Globulin Abnormal |
2.2% |
| Anaemia |
2.2% |
| Asthmatic Crisis |
2.2% |
| Conjunctivitis |
2.2% |
| Depression |
2.2% |
|
